As many as one third of newly diagnosed multiple myeloma (MM) cases are classified as high risk, with widely varying rates of ...
Market Research Report Highlights Key Trends, Drivers, and InnovationsThe DNA sequencing market has emerged as a cornerstone ...
Under the agreement, Hologic ( NASDAQ: HOLX) will co-market Nu.Q ® Discover services of Volition with Hologic Customers for an initial one-year term. If successful, the aim is for Hologic to be ...
University of Maryland School of Medicine Dean Mark T. Gladwin, MD, announced today that Andreea Creanga, MD, PhD, a distinguished and internationally recognized leader in maternal and perinatal ...